Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Catalytica Energy Systems, Inc. (CESI) -- Ignore unavailable to you. Want to Upgrade?

To: gmccon who wrote (1143)	4/12/1998 8:59:00 PM
From: Dan B.	Respond to of 1514

Oh my, I think so too... . Easily. Unrealized potential, when perceived as a near dead lock cinch to bear fruit, usually runs high ahead of results- simply because the positive outcome has a high degree of predictability. This stock may be proving to be such a case as I write. I view Glaxo's limited commitments to use CTAL as only an "out" to lessen litigation in the event of CTAL's poor performance. The addition of Phizer is a strong indication that this has not been the case. I expect contract renewals based on successful performance. CTAL is expanding this plant- showing confidence. Thorough and humble messages of warning from management- yet their actions speak louder than words... . I think they are being heard loud and clear.